FOUNDAYO
Active substance: orforglipron
TABLET, FILM COATED · ORFORGLIPRON CALCIUM 14.5 mg/1
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ORFORGLIPRON CALCIUM · 14.5 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-6a8c-7318-b7d9-09d684fe053a,01a12090-962b-7180-896e-542039369c84,01a12092-7537-780f-92d1-be920f24a6b1,01a12099-5b78-7bf2-b659-9126972b493e,01a1209b-c765-77fb-9a61-2388adb1e213;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-4839
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0002-4839 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-4839 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-4839 · Verified 2026-10-09 · open in source